State Ledger
Company profile

Processa Pharmaceuticals, Inc. CIK 1533743

Ticker
PCSA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Vero Beach, FL 32960
Fiscal year end
2025 (FY)
Market Data
Close
$1.48
Change
-$0.26
Change %
-14.74%
Volume
20,587

PCSA · trading date Oct 9, 2026 · previous close $1.73 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$13.56M
Total assets
$7.81M
Total liabilities
$2.24M
Stockholders' equity
$5.58M
Cash & equivalents
$5.54M
Operating income
-$13.99M
Operating cash flow
-$11.39M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
28.6%
Equity / assets
71.4%
CapEx / revenue
—
Operating cash flow / net income
0.84×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$13.56M $7.81M $2.24M $5.58M
2024 — -$11.85M $3.23M $1.53M $1.70M
2023 — -$11.12M $5.79M $797.5K $4.99M
2022 $0 -$27.42M $8.62M $1.15M $7.47M
2021 $0 -$11.43M $26.46M $978.4K $25.49M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G
2026-08-18
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Vero Beach, FL 32960
601 21ST STREET, SUITE 300
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:25 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies